Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

These patients have been evenly randomized to one of the six dosing arms of the drug or placebo ... expansion for weight loss drugs, fueled by the success of Eli Lilly’s LLY Zepbound and ...

CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as ...

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 (GLP-1) agonists in the medical world. Eli Lilly ( LLY -0.50%) has emerged ...

Not long ago, the FDA announced there's no longer a shortage of Ozempic, Wegovy, Zepbound or similar drugs used for weight ...

Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...

These branded prescription pharmaceuticals – approved by the Food and Drug ... Zepbound® registered trademarks.(5) For example, the clinics’ website promoted “Seattle Zepbound Weight Loss ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...